can tirzepatide cause colitis PDF) Tirzepatide-Associated Colonic Ischemia How should diarrhea caused by

Science (New York, N.Y.) 2008;320:16471651

The most common gastrointestinal symptoms include: Nausea (1220% of patients): Usually mild to moderate, most pronounced 13 days after injection, typically improving within the first month Diarrhea (716% of patients): Often resolves as the body adjusts to the medication Decreased appetite : An expected pharmacologic effect that contributes to weight loss Constipation (57% of patients): May require dietary fiber adjustments or stool softeners Vomiting (28% of patients): Less common but warrants medical attention if persistent Abdominal discomfort or bloating : Related to delayed gastric emptying Most gastrointestinal side effects are mild to moderate in severity and diminish significantly after 48 weeks as tolerance develops

Research shows that roughly 2030% of semaglutide users experience meaningful plateaus, though many can restart progress with strategic adjustments

Although there are currently no FDA-approved oral GLP-1 medications for weight loss, early data from clinical trials hint that a pill form could be as effective as its injectable counterparts